TCM
MRNA icon

Teza Capital Management’s Moderna MRNA Stock Holding History

Teza Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,481
Closed -$584K – 694
2024
Q1 		$584K Buy
+5,481
New +$552K 0.08% 314
2023
Q2 		– Sell
-2,888
Closed -$444K – 668
2023
Q1 		$444K Buy
+2,888
New +$476K 0.1% 295
2021
Q3 		– Sell
-1,887
Closed -$443K – 506
2021
Q2 		$443K Sell
1,887
-9,211
-83% -$1.65M 0.07% 340
2021
Q1 		$1.45M Buy
+11,098
New +$1.61M 0.29% 105
2020
Q1 		– Sell
-22,239
Closed -$435K – 367
2019
Q4 		$435K Buy
22,239
+11,444
+106% +$203K 0.12% 313
2019
Q3 		$172K Buy
+10,795
New +$159K 0.04% 463

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Teza Capital Management's MRNA Position: Q2 2024 in Review

Teza Capital Management sold out of Moderna (MRNA) in Q2 2024, closing a stake of 5,481 shares — an estimated $584K sold.

Teza Capital Management first reported a position in MRNA in Q3 2019 and held it in 6 quarters. The position peaked at $1.45M in Q1 2021. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Teza Capital Management reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Teza Capital Management sold 5,481 Moderna shares in Q2 2024, an estimated $584K.
  • Teza Capital Management first reported a position in Moderna in Q3 2019 and held it in 6 quarters.
  • Teza Capital Management's Moderna position peaked at $1.45M in Q1 2021.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Teza Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.